Even though overall CDK1 expression levels59, 60 predicted better DRFS, similarly, PLK1 alone in cancers, including breast cancer, has been shown to be weak and inconsistent61, 62, 63, in combination both CDK1 and PLK1 predicted poor survival. This evidence concerns the gene CDK1 and breast carcinoma.